Zhongnan Medical Journal Press

Home Results

A total of 25 result was found. Results that relate to Inhibitors

Signal mining of adverse drug reaction related to MET-TKIs after marketing based on FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):300-310.
10463 times 1518 times

WANG Meisa HAN Qiushuang GAO Liang JIANG Yuan CHEN Zhe

Mesenchymal-epithelial transition factor tyrosine kinase inhibitors Food and Drug Administration Adverse Event Reporting System Adverse event signal mining Disproportionality analysis Pharmacovigilance
Details
Application progress of novel targeted drugs in precision treatment of membranous nephropathy

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):467-473.
14148 times 3791 times

CHEN Wei LI Xiaowei

Membranous nephropathy Refractory membranous nephropathy Targeted therapy Anti-CD20 monoclonal antibodies Anti-B-cell activating factor monoclonal antibodies Anti-CD38 monoclonal antibodies Proteasome inhibitors Complement inhibitors Individualized treatment
Details
A case of tumor hyperprogression caused by treatment of lung squamous cancer with serplulimab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(9):1099-1103.
9152 times 1432 times

YING Yuanyuan MOU Yongxiao ZHU Qiuna ZHENG Song LOU Songgao LOU Jiang

Serplulimab Hyperprogression Immune checkpoint inhibitors Adverse drug reaction
Details
Analysis of immune checkpoint inhibitor induced hypothyroidism based on the U.S. FAERS database

Published on Frontiers in Pharmaceutical Sciences 2025,29(7):1186-1191.
8609 times 1118 times

WANG Huiru YANG Hua REN Yanfei CAO Zhibao LI Xue

Immune checkpoint inhibitors Hypothyroidism FDA Adverse Event Reporting System Drug vigilance
Details
Progress of gut microbiota in tumor immunotherapy

Published on New Medicine 2025,35(9):1099-1107.
10838 times 1142 times

ZHANG Xiaoqing SU Rina LIU Shuai ZHANG Kai HE Jing WANG Yuchao LUAN Wei

Gut microbiota Immune system Immune checkpoint inhibitors Tumour therapy
Details
Retrospective analysis of immune checkpoint inhibitor-induced colitis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1390-1398.
3189 times 641 times

SONG Jialin WU Lei WANG Yiting

Immune checkpoint inhibitors Drug-induced colitis Immunotherapy toxicity Risk factors Retrospective analysis
Details
A case of upper gastrointestinal bleeding caused by atezolizumab

Published on Chinese Journal of Pharmacoepidemiology 2025,34(12):1468-1472.
2650 times 555 times

LIU Xinmiao TONG Jingjing

Atezolizumab Upper gastrointestinal bleeding Immune checkpoint inhibitors Adverse drug reactions
Details
Research progress on TGF-β pathway inhibitors for treating hepatic fibrosis

Published on Frontiers in Pharmaceutical Sciences 2026,30(2):347-360.
2084 times 323 times

WU Yalin TIAN Sha

Hepatic fibrosis TGF-β signaling pathway Hepatic stellate cells Inhibitors Therapeutic target Molecular mechanisms Drug delivery systems Traditional Chinese medicine compounds
Details
Rapid health technology assessment of PARP inhibitors in the treatment of recurrent ovarian cancer

Published on Chinese Journal of Pharmacoepidemiology 2026,35(4):439-450.
1320 times 223 times

LI Anna LI Jianping CHEN Wenjun ZUO Jing HUANG Xiaolu MENG Jun

Poly ADP ribose polymerase inhibitors Recurrent ovarian cancer Rapid health technology assessment Efficacy Safety Economy
Details
Signals mining and analysis of adverse drug events of three proton pump inhibitors based on JADER database

Published on Chinese Journal of Pharmacoepidemiology 2026,35(4):388-397.
628 times 163 times

WANG Ziyi YU Binbin

Proton pump inhibitors Adverse drug events Skin and subcutaneous tissue disorders JADER database
Details